← FDA Drug Approvals (Drugs@FDA)

LICART

NDA · New Drug Application · Sponsor: IBSA INST BIO · Approved 2018-12-19

Drug application

FDA Application #

NDA206976

Application type

New Drug Application

Brand name

LICART

Generic name

DICLOFENAC EPOLAMINE

Active ingredients

DICLOFENAC EPOLAMINE

Dosage form

SYSTEM

Route

TOPICAL

Marketing status

Prescription

Sponsor

IBSA INST BIO

Manufacturer

IBSA Pharma Inc.

First approval

2018-12-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown